Sequential Compression Systems Market Size, Share, Trend, Scope Report 2026 to 2035
Share With :
Sequential Compression Systems Market Size is valued at USD 1.37 Bn in 2025 and is predicted to reach USD 3.08 Bn by the year 2035 at a 8.4% CAGR during the forecast period for 2026 to 2035.
Sequential Compression Systems Market Size, Share & Trends Analysis Distribution by Product Type (Consumables & Accessories (Garments, Compression Sleeves, Replacement Tubing & Connectors) and Compression Systems (Portable & Wearable Units, Stationary/Tabletop Units), Application (Lymphedema Management, Sports Recovery & Performance, Deep Vein Thrombosis (DVT) Prevention, Chronic Venous Insufficiency (CVI) & Ulcer Management, and Others), Technology (Simultaneous Sequential Compression (SSC) and Alternate Sequential Compression (ASC)), End-user (Institutional Settings (Hospitals, Rehabilitation & Skilled Nursing Facilities, Specialty Clinics) and Home & Retail, Direct-to-Consumer (DTC) Sports/Fitness Centers, Home Healthcare)), and Segment Forecasts, 2026 to 2035
Sequential Compression Systems Market Key Takeaways:
|
A sequential compression system is a mechanical or therapeutic device that uses inflatable cuffs or chambers to apply controlled pressure in a pattern or sequence along a limb or body part. These systems function by sequentially inflating and deflating air chambers, beginning with the distal part (like the hand or foot) and working their way toward the proximal part (like the upper arm or thigh). This sequential action prevents fluid buildup in tissues, improves lymphatic drainage, and increases blood circulation. The rising incidence of chronic venous conditions such as deep vein thrombosis (DVT) and lymphedema, particularly in the elderly population, is the main driver of the sequential compression systems market's global expansion.
Deep vein thrombosis (DVT), chronic venous illnesses, and cardiovascular ailments are becoming more common, which is pushing the demand for sequential compression systems. These devices are frequently used in hospitals and surgical facilities to enhance blood flow and avoid clot formation, especially in patients having general, cardiology, and orthopedic procedures. Furthermore, the sequential compression systems are in greater demand in both hospital and home care settings due to the rising incidence of venous diseases brought on by aging populations and sedentary lifestyles. Additionally, increasing awareness of postoperative problems, including venous thromboembolism, and the amount of surgical procedures performed globally are driving the sequential compression systems market.
In addition, the use of sequential compression systems as a non-invasive and successful treatment for edema, lymphedema, and circulation-related disorders is being encouraged by the healthcare industry's growing emphasis on early intervention and preventative care. The product uptake is also being boosted by technological developments, including smart monitoring features, portable compression devices, and enhanced patient comfort. Additionally, supporting clinical guidelines that advocate mechanical prophylaxis for DVT prevention and the development of healthcare infrastructure, especially in emerging nations, are anticipated to bolster the sequential compression systems market growth. However, some of the main issues impeding the sequential compression systems market expansion are the adoption of alternative technologies and an insufficient reimbursement system for these devices.
• Cardinal Health
• Hyperice
• Bio Compression Systems
• Enovis
• AIROS Medical
• Therabody
• Mego Afek
• Zimmer Biomet
• Tactile Medical
• BREG, Inc.
• Arjo
The rising incidence of venous thromboembolism (VTE), which includes deep vein thrombosis (DVT) and pulmonary embolism, especially among hospitalized and postoperative patients, is one of the main factors propelling the sequential compression systems market. The danger of blood clot development is greatly increased by factors such as the increasing frequency of orthopedic, cardiovascular, and general surgeries, longer hospital stays, and restricted patient mobility. As a non-invasive mechanical prophylactic technique, sequential compression systems are frequently advised to enhance venous blood flow and lessen the risk of clot formation in the lower extremities. Furthermore, these devices are in greater demand in hospitals, ambulatory surgical centers, and home care settings due to the growing global aging population and the rising prevalence of lifestyle-related conditions such as obesity, diabetes, and cardiovascular diseases.
The sequential compression systems market is challenged by the high cost of sophisticated compression equipment and associated accessories, which may prevent adoption in smaller hospitals and healthcare facilities with tighter budgets. In developing nations, where knowledge of mechanical prophylaxis is still low, many healthcare facilities may give priority to basic medical equipment over specialized devices for thrombosis prevention. Moreover, the operational expenses may also rise due to the requirement for routine maintenance, disposable sleeves, and qualified medical personnel to operate and keep an eye on the devices. These operational and budgetary obstacles may hinder the broad adoption of sequential compression systems, particularly in low- and middle-income nations, hence limiting the expansion of the sequential compression systems market.
The compression systems category held the largest share in the Sequential Compression Systems market in 2025 because it is widely used in hospitals, surgical facilities, and post-acute care settings to prevent venous thromboembolism (VTE). These devices are essential to standardized DVT prophylaxis programs because they provide controlled, intermittent pneumatic compression with consistent pressure precision, making them preferred over accessories and clothing alone. Furthermore, the ongoing technological developments, such as portable, tubeless, and smart compression devices, growing use in home-based care, and an increase in surgery volumes worldwide, all contribute to the segment's expansion of the installed base of compression systems.
In 2025, the deep vein thrombosis (DVT) prevention category dominated the Sequential Compression Systems market because extended immobility and surgical treatments are linked to thromboembolic consequences that are becoming more widely recognized. In hospitals and surgical facilities, sequential compression devices are frequently utilized as a mechanical prophylactic technique to lower the risk of blood clot development in deep veins, especially in patients having abdominal, cardiovascular, and orthopedic procedures.
The Sequential Compression Systems market was dominated by North America region in 2025 due to the advantageous reimbursement policies, strong healthcare infrastructure, and high frequency of vascular illnesses linked to lifestyle. A mature and competitive environment has been created by the existence of significant sequential compression systems market competitors, ongoing technological advancement, and robust clinical research efforts. Additionally, the region's leadership position is further reinforced by its proactive approach to DVT prevention in immobile and post-surgical patients, as well as by strict regulatory standards guaranteeing device efficacy and safety. Moreover, the ongoing need for sequential compression systems in North America is partly influenced by the aging population and increased patient and healthcare provider knowledge of the dangers of venous thromboembolism.
• November 2024: The next-generation Kendall SCD SmartFlow Compression System, which is intended to enhance patient comfort and clinician workflow, was introduced in the United States by Cardinal Health. In addition to improving circulation and lowering pain and swelling related to venous stasis, the system uses clinically proven technology that provides tailored intermittent pneumatic compression (IPC) to improve blood flow in at-risk patients, supporting the prevention of venous thromboembolism (VTE).
| Report Attribute | Specifications |
| Market size value in 2025 | USD 1.37 Bn |
| Revenue forecast in 2035 | USD 3.08 Bn |
| Growth Rate CAGR | CAGR of 8.4% from 2026 to 2035 |
| Quantitative Units | Representation of revenue in US$ Bn and CAGR from 2026 to 2035 |
| Historic Year | 2022 to 2025 |
| Forecast Year | 2026-2035 |
| Report Coverage | The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
| Segments Covered | Product Type, Application, Technology, End-user, and By Region |
| Regional Scope | North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
| Country Scope | U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; China; Japan; India; South Korea; Southeast Asia; South Korea; Southeast Asia |
| Competitive Landscape | Cardinal Health, Hyperice, Bio Compression Systems, Enovis, AIROS Medical, Therabody, Mego Afek, Zimmer Biomet, Tactile Medical, BREG, Inc., and Arjo |
| Customization Scope | Free customization report with the procurement of the report, Modifications to the regional and segment scope. Geographic competitive landscape. |
| Pricing and Available Payment Methods | Explore pricing alternatives that are customized to your particular study requirements. |
• Lymphedema Management
• Sports Recovery & Performance
• Deep Vein Thrombosis (DVT) Prevention
• Chronic Venous Insufficiency (CVI) & Ulcer Management
• Others
• Simultaneous Sequential Compression (SSC)
• Alternate Sequential Compression (ASC)
• Institutional Settings
o Hospitals
o Rehabilitation & Skilled Nursing Facilities
• Specialty Clinics
o Home & Retail
o Direct-to-Consumer (DTC) Sports/Fitness Centers
o Home Healthcare
North America-
• The US
• Canada
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• South East Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Mexico
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of Middle East and Africa
This study employed a multi-step, mixed-method research approach that integrates:
This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.
Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.
Secondary data for the market study was gathered from multiple credible sources, including:
These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.
Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.
Primary interviews for this study involved:
Interviews were conducted via:
Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.
All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.
The data validation process included:
This ensured that the dataset used for modelling was clean, robust, and reliable.
The bottom-up approach involved aggregating segment-level data, such as:
This method was primarily used when detailed micro-level market data were available.
The top-down approach used macro-level indicators:
This approach was used for segments where granular data were limited or inconsistent.
To ensure accuracy, a triangulated hybrid model was used. This included:
This multi-angle validation yielded the final market size.
Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.
Given inherent uncertainties, three scenarios were constructed:
Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.